Participants with myofascial pain syndrome in upper trapezius muscles Myofascial pain syndrome
Conditions
Interventions
10 ml of 10% dextrose solution is used in ultrasound-guide interfacial injection in targeted muscles ,As in routine practice, 10 ml of 1% lidocaine injection is used in ultrasound-guide interfacial in
Active Comparator Drug,Active Comparator Drug
10% dextrose solution,1% lidocaine solution
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >/= 18 years old 2. Have symptoms and signs consistant with myofascial pain syndrome of upper trapezius muscles and these symptoms persist more than 3 months 3. Self reported pain score >/= 4 from numeric rating scale (NRS) 0-10
Exclusion criteria
Exclusion criteria: 1. Has been diagnosed with cervical radiculopathy or history of cerival myelopathy 2. Previos history of surgery related to cervical and neck region within 1 year 3. Previos history of steroid and/or local anesthetic agent injection in the affected neck or shoulder side within 1 year 4. Have signs and symptoms of fibromyalgia 5. History of allergy to lidocaine or dextrose solution 6. Has one of these contraindication for injection such as skin infection in injected region, coagulapathy problem etc. 7. Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms pain intensity Before procedure; Immediately post-procedure, at 72 hr and 2 weeks post-procedure NRS | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain intensity during injection immediately post-procedure NRS,Cervical Range of Motion before procedure; immediately and at 2 weeks post-procedure degree of motion,Neck functional score before procedure and at 2 week after procedure Neck Disability Index | — |
Contacts
Public ContactPatsaree Pattanasuwanna
Nakhon Pathom Hospital
Outcome results
None listed